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Abstract
The chemokine receptor CXCR4 and its ligand CXCL12 have been shown to mediate the metastasis of many malignant
tumors including breast carcinoma. Interaction between hepatocyte growth factor (HGF) and the Met receptor tyrosine
kinase mediates development and progression of cancers. HGF is able to induce CXCR4 expression and contributes to
tumor cell invasiveness in breast carcinoma. However, the mechanism of the CXCR4 expression modulated by c-Met-HGF
axis to enhance the metastatic behavior of breast cancer cells is still unclear. In this study, we found that HGF induced
functional CXCR4 receptor expression in breast cancer cells. The effect of HGF was specifically mediated by PKCf activity.
After transfection with PKCf-siRNA, the phosphorylation of PKCf and CXCR4 was abrogated in breast cancer cells.
Interference with the activation of Rac1, a downstream target of HGF, prevented the HGF-induced increase in PKCf activity
and CXCR4 levels. The HGF-induced, LY294002-sensitive translocation of PKCf from cytosol to plasma membrane indicated
that HGF was capable of activating PKCf, probably via phosphoinositide (PI) 3-kinases. HGF treatment also increased MT1-
MMP secretion. Inhibition of PKCf, Rac-1 and phosphatidylinositol 3-kinase may attenuate MT1-MMP expression in cells
exposed to HGF. Functional manifestation of the effects of HGF revealed an increased ability for migration, chemotaxis and
metastasis in MDA-MB-436 cells in vitro and in vivo. Our findings thus provided evidence that the process of HGF-induced
functional CXCR4 expression may involve PI 3-kinase and atypical PKCf. Moreover, HGF may promote the invasiveness and
metastasis of breast tumor xenografts in BALB/c-nu mice via the PKCf-mediated pathway, while suppression of PKCf by
RNA interference may abrogate cancer cell spreading.
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Introduction
Identification of novel therapeutic targets is critical for the
treatment of malignant tumors, breast cancers in particular [1,2].
A quite exciting one of such targets is the chemokine (C-X-C
motif) receptor 4 (CXCR4) expressed in various types of tumors
[3]. In breast cancer cells, CXCR4 is a major chemokine receptor
with possible but undefined roles in metastatic cell diffusion and
homing to secondary sites [4]. Most models of CXCR4 functions
in tumor focus on its potential role as a mediator of motility,
invasiveness and metastatic behaviors [5,6]. Blocking CXCR4
may attenuate breast cancer metastasis to regional lymph nodes
and the lungs [7], and activation of CXCR4 is believed to be
primarily ligand-dependent, as is supported by the antitumor
efficacy of AMD 3100, an antagonist of chemokine (C-X-C motif)
ligand 12 (CXCL12) binding [8]. CXCR4 is phosphorylated in
response to ligand binding in a G protein-coupled receptor kinase
2-dependent fashion [9]. Phosphorylation of CXCR4 can also
occur in response to the activation of other receptors and can
involve additional kinases, such as protein kinase C f (PKCf)
[10,11] or tyrosine kinases [12]. Regulation of phosphorylation
and internalization has a significant effect on CXCR4-mediated
cell responses [10]. Thus, understanding the mechanisms and
molecular pathways that affect CXCR4 expression and cellular
signaling might have important implications for breast cancer cell
metastasis.
Hepatocyte growth factor/scatter factor (HGF/SF) is an
important fibroblast-secreted protein that mediates development
and progression of cancers [13]. HGF has been demonstrated to
transduce its biological activities through the Met receptor tyrosine
kinase by activating a number of intracellular pathways which in
turn transmit the HGF signal to cytosol and to nucleus [14,15,16].
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that are important for these processes, including HIF-1a (the
inducible subunit of HIF-1 transcription factor), members of the
plasminogen activation system and the C-X-C motif receptor 4
(CXCR4) [17,18]. The receptor tyrosine kinases Met and CXCR4
are associated with the morphogenesis and functional differenti-
ation of normal mammary gland epithelium and play an
important role in malignant transformation [19]. Previously, both
CXCR4 and c-Met were shown to be upregulated by hypoxia in
glioma cells and breast cancer cells [17,18,19,20]. HGF up-
regulates CXCR4 expression via NF-kappaB and contributes to
cell invasion. Knock-down of NF-kappaB expression inhibited the
induction of CXCR4 expression in response to HGF [21,22]. In
the cases of liver injury, HGF can promote the expression of
CXCR4 in human CD34 stem cells, and subsequently, CD34
stem cells migrate to the injury site under the directional guidance
of chemokine stromal cell-derived factor-1 (SDF-1, also named
CXCL12). The protein kinase C family (PKC) has been shown to
be involved in the expression and function of CXCR4, and is also
linked to HGF-induced intracellular signal transduction in tumor
cells. It is therefore vitally important to understand whether PKC
pathway is associated with the expression and function of CXCR4
induced by HGF [13,23].
A specific isoform of the PKC family, the atypical PKCf,i sa n
important class of secondary messengers that mediates a number
of cellular responses to exogenous stimuli and stress agents. Unlike
conventional (a,b,c) and novel (d, e, g, h) PKC isoenzymes,
atypical PKCs(aPKCs) include PKCf and PKCl/i which are not
activated by calcium and diacylglycerol [24]. The atypical PKCf is
a key regulator of CXCL12/CXCR4-activated signaling in
human hematopoietic progenitors. Petit I et al have demonstrated
that ectopic PKCf expression increases SDF-1 induced motility,
whereas inhibition of PKCf activity impairs survival, proliferation,
adhesion and engraftment of immature CD34
+ progenitors [25].
Findings of other studies [26,27] have positioned PKCf in the
center of chemoattractant and immunoregulator-induced respons-
es. Activation/phosphorylation of PKCf by HGF is an essential
intracellular signaling requirement for growth factor-inducedb-cell
proliferation [28]. Recent reviews also described the involvement
of atypical PKCf/i in HGF-induced Ras-related C3 botulinum
toxin substrate (Rac) activation and membrane ruffling of colony
growing epithelial cells [23]. Therefore, we speculated that PKCf
may be involved in HGF-induced CXCR4 expression in breast
cancer, and may affect the behaviors of migration and invasion in
breast cancer cells.
In the present study, we demonstrated that HGF-induced
activation of PKCf increases CXCR4 expression and the
migratory capacity of MDA-MB-436 breast cancer cells. A
molecular analysis of these events indicated that augmented
CXCR4 expression was regulated by PKCf activity. The
phosphatidylinositol 3 (PI 3)-kinase and protein kinase B (PKB/
AKT) pathways were involved in CXCR4 expression and the
HGF-induced activation of PKCf. The functional importance of
HGF-induced PKCf activation in breast cancer metastasis was
further demonstrated in a xenograft experiment in which the
suppression of PKCf abrogates HGF-induced metastasis of breast
cancer to the lung and liver.
Results
HGF/c-Met or CXCR4 expression in breast carcinomas
correlated with tumor invasiveness
High level of HGF/c-Met expression is considered as a possible
indicator of metastasis, earlier recurrence and shortened survival
in breast cancer patients [29]. In the tumor microenvironment,
HGF regulates the expression of c-Met and CXCR4 through
autocrine or paracrine actions [13,17]. Moreover, the chemokine
receptor CXCR4 has been shown to be one of the vital factors for
metastasis in breast cancer patients [7]. Initially, we intended to
establish whether c-Met and CXCR4 are also expressed on breast
cancer cells in clinically resected tissues. To do this, we determined
the expression of HGF, c-Met and CXCR4 in breast cancer tissues
by immunohistochemistry using corresponding antibodies, which
revealed positive immunostaining of HGF, c-Met or CXCR4 in
197 cases of invasive breast carcinoma. In contrast, c-Met
+ and
CXCR4
+ cells were not found to be present in any of the benign
breast tissues with or without atypical epithelial hyperplasia
(Figure 1A).
When the c-Met
+ and CXCR4
+ cell counts in breast cancer
were calculated according to the clinicopathology of these patients
(Table S1), the numbers of HGF
+, c-Met
+ or CXCR4
+ cells
increased along with the histopathological grading of the tumor
(P,0.001) (Figure 1B, Table S1). In addition, c-Met
+ or CXCR4
+
cell infiltration appeared to be more intense in those with axillary
lymph node (P,0.001) or distal metastasis (P,0.001) (Table S1).
These findings linked the enhanced expression of c-Met and
CXCR4 to invasiveness and metastasis of breast cancers.
HGF upregulated CXCR4 protein expression and
membrane presentation in human breast cancer cells
Tumor development involves an intricate set of molecular
events driven by different environmental stimuli. Changes in
stromal cell-released cytokines (proinflammatory cytokines, che-
mokines and growth factors) seem to influence the gene expression
profile in malignancy and to determine the cell fate [30]. To
further study the effect of HGF on CXCR4 expression, MDA-
MB-436 and MCF-7 breast cancer cell lines with different grades
of malignancy were cultured in the presence or absence of HGF or
SDF-1 for 24 hours. Treatment with HGF was found to result in a
2- to 7-fold increase in CXCR4 mRNA and protein expression in
the MDA-MB-436 and MCF-7 cells (Figures 2A–2B, Figure S1A).
To study the level of Met expression and the effect of HGF on Met
expression, MDA-MB-436 and MCF-7 breast cancer cell lines
were cultured in the presence or absence of HGF or SDF-1 for
24 hours. Treatment with HGF was found to result in increased
Met phosphorylation but not Met expression in the MDA-MB-436
and MCF-7 cells (Figure 2B, Figure S1B).
To study the possible correlation between the patterns of
CXCR4 mRNA and protein expression, we evaluated mRNA or
protein expression of CXCR4 after HGF treatment by quantita-
tive RT-PCR (qRT-PCR) or immunoblotting (Figures 2C–2D)
and flow cytometry (Figure 2E). The level of CXCR4 mRNA
increased by approximately 2 to 9 folds between 4 and 12 hours
after HGF treatment, and then declined gradually (Figure 2C).
The level of CXCR4 protein began to increase by 4 hours,
doubled between 8 and 16 hours, and was approximately 2- to 6-
fold higher than in the starved cells at 24 hours after HGF
treatment (Figures 2D–2E, Figure S1B). The difference in the time
course was probably consistent with the time required for protein
synthesis, although we cannot exclude the possible involvement of
post-transcriptional mechanisms therein. Our study also found
that HGF treatment promoted the expression of CXCR4 and led
to CXCR4 phosphorylation. In contrast, SDF-1, the ligand of
CXCR4, another important cytokine functioning in a different
way, was also found to cause CXCR4 phosphorylation but did not
increase expression of CXCR4 mRNA and protein in MDA-MB-
436 and MCF-7 cells (Figures 2A–2B, Figure S1A). Changes in the
membrane and intracellular CXCR4 levels were then compara-
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with HGF. While cell surface (membrane) expression of the
receptor was upregulated by 2.5-fold, only a 1.4-fold increase was
found for the level of intracellular CXCR4 (Figure 2F). Further-
more, a time course analysis of surface-bound anti-CXCR4 mAb
internalization showed that CXCR4 receptor endocytosis was
reduced by 2-fold in HGF-stimulated cells compared with
untreated counterparts (Figure 2G), suggesting that in the absence
of ligand, HGF stimulation may contribute to longer duration for
CXCR4 to be detectable on cell membrane.
Figure 1. Immunohistochemical staining of HGF, c-Met and CXCR4 in breast cancer specimens. Original magnification, 4006. (A)
Representative micrographs of immunohistochemical results for negative HGF, c-Met or CXCR4 staining in breast benign diseases (an atypical
hyperplasia or carcinoma in situ) and for positive HGF, c-Met or CXCR4 staining in an invasive breast carcinoma; (B) Representative micrographs of
immunohistochemical results for positive HGF, c-Met and CXCR4 staining cell counts, where the intensity of immunohistochemical staining correlates
with the histopathological grading of invasive breast carcinomas.
doi:10.1371/journal.pone.0029124.g001
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PLoS ONE | www.plosone.org 3 January 2012 | Volume 7 | Issue 1 | e29124Figure 2. HGF upregulates CXCR4 expression and membrane presentation in human breast cancer cells. (A). qRT-PCR analysis of the
total CXCR4 mRNA extracted from HGF- or SDF-1-treated MDA-MB-436 and MCF-7 cells. Results are presented as the mean 6 SD of three
independent experiments. # P,0.01 as compared to PBS. (B). Western blot analysis of the total protein expression and phosphorylation levels of Met
or CXCR4 in MDA-MB-436 and MCF-7 cells cultured for 24 hours with and without the presence of 50 ng/ml HGF or 20 ng/ml SDF-1. The experiment
was repeated twice with similar results. A representative study is shown. (C). Time course of the relative extracted CXCR4 mRNA expression in MDA-
MB-436 and MCF-7 cells following stimulation with 50 ng/ml HGF. Results are presented as the mean 6 SD of three independent experiments.
# P,0.01,* P,0.05 as compared to PBS. (D). Western blot analyses of CXCR4 protein expression in HGF-treated MDA-MB-436 and MCF-7 cells. The
experiment was repeated three times with similar results. A representative study is shown. (E). Flow cytometric analysis of MDA-MB-436 cells stained
for the expression of CXCR4 using a CXCR4 monoclonal antibody and isotype controls. The experiment was repeated three times with similar results.
A representative study is shown. (F). Increased membrane and intracellular CXCR4 labeling in MDA-MB-436 cells incubated for 24 hours in the
presence of 50 ng/ml HGF compared with untreated cells (PBS) taken as 1. Flow cytometry analysis data (mean6SD of three independent
experiments) are shown. # P,0.01,* P,0.05 as compared to PBS. (G). Decreased internalization rate of anti-CXCR4-PE mAb in MDA-MB-436 cells
treated for 24 hours with HGF compared with PBS. Results are presented as the mean 6 SD of three independent experiments. * P,0.05 as
compared to PBS at each time point.
doi:10.1371/journal.pone.0029124.g002
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To investigate the mechanisms underlying the effects of HGF
on CXCR4 expression we examined downstream constituents of
the HGF-activated pathway in MDA-MB-436 cells. Studies have
shown that cell responses to HGF/SF binding involve activation of
different functional PKC subspecies that are associated with
enhanced cell migration and growth [14,29]. We thus focused on
PKCf which had recently been implicated in HGF-induced
signaling [23].
Activation of PKC requires phosphorylation by an upstream
kinase which results in translocation to the plasma membrane
where PKC can phosphorylate its substrate. To verify whether
HGF/SF activates conventional or novel PKC isoforms in MDA-
MB-436 cells, we performed western blot analyses of extracts from
treated and unstimulated cells, and found that HGF had a major
effect on PKCf activity. As shown in Figure 3A, the level of
phosphorylated PKCf in MDA-MB-436 and MCF-7 cells
increased by approximately 3- to 10-fold within 5 to 60 minutes
after HGF treatment, in consistency with a hallmark feature of
PKCf activation (Figure 3A, Figure S2A). To obtain an
appreciable down-regulation of cellular atypical PKCs, we
silenced PKCf using different combinations of specific siRNAs.
This resulted in impairment of HGF-induced expression and
phosphorylation of both PKCf and CXCR4 (Figures 3B–3C,
Figures S2B–2C). Addition of the PKCf inhibitory pseudosub-
strate (PSf) was shown to substantially affect the basal CXCR4
expression and completely abrogated HGF-induced CXCR4
expression in MDA-MB-436 cells (Figures 3D–3E). In contrast,
inhibition of other PKC isoenzymes (PKCe and PKCa/b) did not
produce any change in CXCR4 expression and phosphorylation
(Figure 3D, Figures S2D–2E)). Moreover, after treatment with
cholesterol sulfate (a chemical activator of PKCf [31]), the
expression of membrane CXCR4 proteins in MDA-MB-436 cells
was significantly enhanced (Figure 3E), which was similar to that
in HGF-treated cells.
Members of the Rac small GTPases family have been
implicated in the spread and dissociation of the HGF-induced
activation of the Cdc42/Rac-regulated p21-activated kinase (PAK)
and c-Jun N-terminal kinase to membrane ruffles [32]. An
increasing body of evidence indicates that Rac mediates the
localization and activation of atypical PKCf in epithelial cells
[23,33]. Therefore, we examined the involvement of Rac-GTPases
in HGF-induced PKCf activation, and found that treatment with
HGF increased Rac1 activity in MDA-MB-436 and MCF-7 cells
(Figure 3F, Figure S2F). For an insight into this observation, our
test with NSC23766 (a Rac-specific small-molecule inhibitor that
targets Rac activation by GEF [34]) demonstrated that the HGF-
induced increase in Rac1 activities can be blocked by Rac1
inhibitor, and that the activities of Rac1 was involved in HGF-
induced PKCf phosphorylation. The concentration of Rac1
inhibitor was inversely associated with the level of HGF-induced
PKCf phosphorylation (Figure 3G, Figure S2G). To directly test
the role of total Rac activation levels in regulating HGF-induced
PKCf phosphorylation in breast cancer cells, levels of Rac1 were
knocked down using RNA interference with small interfering
(si)RNA. Reductions in Rac protein levels resulted in proportional
changes in Rac activity, and in turn, interfered with PKCf
phosphorylation and expression of CXCR4 (Figure 3H, Figure
S2H). Immunocytochemical analysis revealed that NSC23766
completely abrogated the HGF-induced translocation of PKCf
from cytoplasm to cell membrane in MDA-MB-436 cells
(Figure 3I), suggesting that functional Rac1 might be required
for PKCf activation by HGF. Importantly, blocking Rac1
activation in MDA-MB-436 cells caused a reduction in membra-
nal and intracellular CXCR4 expression comparable to that of
PSf or PKCf siRNAs in a manner that was neither synergistic nor
additive in the presence of the both inhibitors (Figure 3C–3D,
Figure 3I).
This result supported our hypothesis that Rac1 and PKCf are
involved in the same pathway in HGF-stimulated elevation of
CXCR4 expression.
HGF-induced CXCR4 expression was functional and
depended on PKCf for its activity
The role of CXCR4 in cancer depends on whether it is in an
activated signaling state. CXCR4 is phosphorylated in response to
binding of CXCL12 in a G protein-coupled receptor kinase 2-
dependent fashion [35]. Receptor phosphorylation stimulates the
interaction between b-arrestin and the carboxy terminus [36].
Phosphorylation of CXCR4 can also occur in response to the
activation of other receptors and involve additional kinases such as
protein kinase C [37] or tyrosine kinases [12]. To better define the
significance of HGF-induced CXCR4 expression, we designed the
following experiments. The first set of experiments was based on
western blot analysis of MDA-MB-436 cells treated with HGF or
SDF-1. The level of phosphorylated CXCR4 was dramatically
increased after treatment with either HGF or SDF-1 (Figure 2B,
Figure S1A). Cholesterol sulfate increased the level of phosphor-
ylated CXCR4 similarly to as found in HGF-treated cells.
Addition of PKCf inhibitory PSf was found to substantially affect
the expression of phosphorylated CXCR4. In contrast, inhibition
of other PKC isoenzymes (PKCe and PKCa/b) produced no
change in expression of phosphorylated CXCR4 (Figure 3D,
Figure S2E).
To better understand the steps in which CXCR4 may
contribute to HGF-induced invasion, we examined the migration
and chemotatic activities of MDA-MB-436 cells in response to
HGF stimulation. As shown by the wound healing assays, the
migration of HGF-stimulated cell was more efficient compared
with PBS-treated cells (Figures 4A–4B), occurring in a dose-
dependent manner (Figure 4C). In the presence of 10 mMP S f or
1 mM AMD3100 (a small-molecule inhibitor of CXCR4), HGF-
induced migration was inhibited, which further supported our
hypothesis that HGF-stimulated MDA-MB-436 cell migration is
mediated by the CXCR4/PKCf pathway (Figure 4B). We then
examined the chemotactic effects of CXCR4 using HGF and
SDF-1 gradients. SDF-1 was found to induce the chemotaxis of
MDA-MB-436 cells in a dose-dependent manner. HGF-induced
chemotaxis also exhibited a typical bell-shaped dose-response
curve, and the chemotaxis indexes were 1.5-fold greater than those
with SDF-1 induction (Figure 4D–4E). Adding PSf or cheler-
ythrine chloride (an inhibitor of all PKCs) substantially affected
and even abrogated HGF-induced chemotaxis in MDA-MB-436
cells. In contrast, PKCe and PKCa/b, the other PKC isoenzyme
inhibitors, had no effect on HGF-induced chemotaxis (Figure 4E).
Given that HGF induces CXCR4 expression, and that HGF as
well as CXCR4/SDF-1 interaction plays an important role in
metastasis, we set to examine whether the SDF-1/CXCR4
interaction contributes to HGF-induced invasive activities. Inva-
sion assays were performed using transwell invasion chambers.
When 50 ng/ml of HGF was added to the supplemented medium,
there was a 3- to 5-fold increase in the number of invading cells as
compared with the PBS-treated cells. These results indicated that
HGF enhanced the invasive activity of MDA-MB-436 cells toward
SDF-1 in vitro (Figure 4F, Figure S3A–3B). The results showed
that HGF did not influence cancer cell viability and proliferation
(Figure S3C–3D). These data were consistent with previous report
PKCf Induced by HGF Increases CXCR4 Expression
PLoS ONE | www.plosone.org 5 January 2012 | Volume 7 | Issue 1 | e29124PKCf Induced by HGF Increases CXCR4 Expression
PLoS ONE | www.plosone.org 6 January 2012 | Volume 7 | Issue 1 | e29124[38]. Moreover, the HGF-induced invasion was inhibited by
PKCf-siRNAs, as well as the effect of PSf. Conversely, PSe and
PSa/b had no effect on HGF-induced invasion (Figure 4F, Figure
S3A–3B). In agreement with our findings implicating Rac1 activity
in HGF-induced PKCf activation (Figures 3H–3I), we found that
Rac1 inhibited the effect of HGF-induced invasion of MDA-MB
436 cells.
To further define the role of PKCf in HGF-stimulated
processes, we looked at other possible targets of PKCf that could
stimulate metastasis of these cells. The experiments were based on
the reports that HGF is a potent activator of membrane type-1
matrix metalloproteinase (MT1-MMP) in breast cancer cells [39],
in a PKCf-dependent manner [40], is a proteolytic enzyme known
to be involved in degrading extracellular matrix and assist in
cancer invasion and progression. MT1-MMP in coordination with
CXCR4 promotes invasion and dissemination of the tumor [41].
Surprisingly, we found that HGF treatment also increased MT1-
MMP expression by MDA-MB 436 cells. Inhibition of PKCf,
Rac-1 and phosphatidylinositol 3-kinase by their respective
inhibitors PSf, NSC23766 and LY290042 attenuated MT1-
MMP expression in MDA-MB 436 cells (Figure 4G–4H, Figure
S3E). These data were consistent with previous reports [42,43].
Therefore, the proper function of MT1-MMP may depend on
both cellular expression and specific membrane localization. Rac1
may be involved in both processes.
These findings implied that up-regulation of CXCR4 by HGF
was essential for in vitro migration and invasion via the CXCR4/
PKCf-mediated pathway. HGF induction of Rac1 activation and
MT1-MMP production implied that cell migration and proteolysis
are two essential processes during tumor invasion and metastasis.
Our data suggested that PKCf stimulation and CXCR4
expression increased the in-vitro migration and invasion of
HGF-treated MDA-MB-436 cells.
HGF-induced CXCR4 expression was mediated via
activation of the PI 3-kinase and AKT signaling modules
In an attempt to identify the pathway leading to PKCf
activation, we investigated the role of phosphatidylinositol
triphosphate-kinase (PI 3K) which has been proposed to activate
PKCf [44]. Akt is a pivotal effector immediately downstream of
the PI 3K and has been implicated in G protein-coupled receptor-
mediated chemotaxis [45]. The HGF-induced Akt activation is
reflected by an increase in phosphorylated Akt [46]. To verify
whether HGF activates Akt phosphorylation in MDA-MB-436
cells, we performed western blot analyses of extracts from treated
and unstimulated cells, and found that HGF had a major effect on
Akt activity. Adding PI 3K inhibitors LY294002 and wortmannin
was shown to partially prevent the phosphorylation of AKT in
MDA-MB-436 cells (Figure 5A, Figure S4A). Furthermore,
LY294002 and AKT inhibitor III inhibited PKCf phosphoryla-
tion and membrane CXCR4 expression, which suggested that
PKCf exerted its function downstream of the PI 3-kinases
signaling pathway (Figures 5B–5C, Figure S4B). Pretreatment
with LY294002 was also found to prevent translocation of PKCf
and CXCR4 to the plasma membrane (Figure 5D), demonstrating
that PKCf activation depended on PI3K activity.
Rac1 reportedly acts as a downstream effector of PI3-kinase in
several growth factor-stimulated pathways [47]. Rac1 activation is
often dependent on PI3-kinase activity, and inhibitors of PI3-
kinase block Rac1 activation. To verify whether HGF activates
Rac1 activities in MDA-MB-436 cells and the relationship of Rac1
and PI3K pathway, we performed Rac1 activity assay analyses of
extracts from treated and unstimulated cells, and found that HGF
can increase Rac1 activities. Adding PI 3K inhibitors LY294002
and wortmannin was shown to partially decrease the activity of
Rac1 in MDA-MB-436 cells (Figure 5A, Figure S4A). Our studies
conformed that PI3-kinase inhibitors can suppress Rac1 activities,
which further suggested that the PI3-kinase regulate the activity of
small GTPases Rac1 [48].
These findings implied that functional CXCR4 expression
induced by HGF might involve a pathway of activation of the PI
3K/Akt and PKCf, and that signals stimulated by HGF passed
from PI 3K/Akt to Rac1 and then to PKCf.
HGF enhanced CXCR4 expression via PKCf and promoted
the invasion and metastasis of breast cancers in vivo
To further examine the effects of HGF-induced CXCR4
expression via PKCf on breast cancer invasion and metastasis in
vivo, we inoculated the mammary fat pads of athymic nude mice
with MDA-MB-436 cells. Cancer metastasis to the lung and liver
of the mice was evaluated when the xenografts reached 1.5 cm in
diameter. Biweekly intratumoral injection with HGF at a dosage of
30 mg/kg for 4 consecutive weeks enhanced the penetration of
MDA-MB-436 cancer cells into the adjacent normal tissues, which
was not seen with PBS injection (Figure 6A).
Moreover, intratumoral injection of HGF conspicuously
increased the number of mice with lung and liver metastasis
(Table S2) but not the size of breast cancer xenografts (Figure S5).
As observed with hematoxylin and eosin (H&E) and PCNA
staining, HGF injection led to more intense infiltration of cancer
cells into the lung and liver of MDA-MB-436 xenograft-bearing
mice than did the PBS injection (Figure 6B). The mean wet lung
weight in HGF-injected tumor-bearing mice was greater as
compared with those injected with PBS or PKCf-shRNA
Figure 3. HGF-induced increase in CXCR4 expression depends on PKCf activity. (A). Time course of relative p-PKCf levels as determined by
immunoblot in MDA-MB-436 and MCF-7 cells following stimulation with 50 ng/ml HGF. The experiment was repeated three times with similar results.
A representative study is shown. (B) and (C). 100 mM PKCf-siRNA1 (si1) or PKCf-siRNA2 (si2) transient transfections and siRNA-mediated PKCf protein
silencing in MDA-MB-436 cells. p-CXCR4 and p-PKCf expression levels in MDA-MB-436 cells cultured for 24 hours with 50 ng/ml HGF or/and 100 mM
PKCf-siRNA1 (si1) or PKCf-siRNA2 (si2). The experiment was repeated three times with similar results. A representative study is shown. (D). Western
blot analysis of total CXCR4 expression and p-CXCR4 levels in MDA-MB-436 cells cultured for 24 hours with 50 ng/ml HGF, 2 mM cholesterol sulfate
(Choles sul), or PBS. As indicated, 10 mM PS of PKCf (PSf), PKCe (PSe), or PKCa/b (PSa/b)o r2 5mM NSC23766 (Rac1 inhibitor, Rac1 inh) was used. The
experiment was repeated three times with similar results. A representative study is shown. (E). Membrane CXCR4 expression in MDA-MB-436 cells
incubated for 24 hours with 50 ng/ml HGF, 2 mM Choles Sulfate, or PBS. Where indicated, 10 mMP So fP S f,P S e,o rP S a/b was used. The flow
cytometry analysis data are shown in arbitrary units (AU) normalized to PBS as the mean 6 SD of three independent experiments. # P,0.01 as
compared to PBS. (F). Western blot analysis of Rac1-GTP and total-Rac1 in MDA-MB-436 and MCF-7 cells treated with 50 ng/ml HGF with or without
25 mM NSC23766. The experiment was repeated three times with similar results. A representative study is shown. (G). Dose-dependent inhibition of
HGF-induced p-PKCf was achieved using NSC23766 in HGF-treated MDA-MB-436 cells; the cells were assayed by western blot. The experiment was
repeated three times with similar results. A representative study is shown. (H). Western blot analysis of Rac1, PKCf and CXCR4 expression in MDA-MB-
436 cells cultured for 48 hours with 100 mM Rac1-siRNA. The experiment was repeated three times with similar results. A representative study is
shown. (I). Cellular distribution of PKCf (left panel) and CXCR4 (right panel) before and after HGF (50 ng/ml) or NSC23766 (50 mM) stimulation for
10 minutes. Representative of two independent experiments was shown.
doi:10.1371/journal.pone.0029124.g003
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PLoS ONE | www.plosone.org 8 January 2012 | Volume 7 | Issue 1 | e29124(Figure 6C). This result was further quantified by qRT-PCR for
human HPRT, which demonstrated that HGF increased the
number of metastatic breast cancer cells in the lung and liver of
MDA-MB-436 xenograft-bearing mice by about 7- and 4-fold,
respectively, as compared with PBS injection (Figure 6D).
Collectively, these data suggested that HGF enhanced the
metastasis of breast cancer xenografts to the lung and liver.
HGF injection failed to enhance the peritumoral penetration of
MDA-MB-436 xenografts infected with PKCf-shRNA but not
GFP-shRNA (Figure 6A, Figure S8). Moreover, the prometastatic
effect of HGF on MDA-MB-436 xenografts was tremendously
alleviated by infection with PKCf-shRNA but not GFP-shRNA
(Table S2). Immunoblot and immunohistochemistry with the anti-
phospho-PKCf or anti-phospho-CXCR4 antibody further con-
firmed that PKCf-shRNA reduced the expression of phosphory-
lated PKCf and HGF-induced phosphorylated CXCR4 in cancer
cells of the MDA-MB-436 xenografts (Figures 6E–6G, Figures
S6,S7). These findings shed light on the HGF-enhanced
invasiveness of cancer cells via PKCf in tumor-bearing mice.
Discussion
The present study addressed the molecular aspects of the
regulation of CXCR4 in human breast cancer cells. Our results
showed that CXCR4 expression was increased and PKCf activity
involved in the HGF-mediated effects. We demonstrated that in
breast cancer cells, PKCf was directly stimulated by HGF-
activated signaling. Furthermore, blocking PKCf activity in
MDA-MB-436 cells was found to significantly abrogate membrane
CXCR4 expression. Importantly, inhibition of several other PKC
isoenzymes did not produce any effect on MDA-MB-436 cells in
terms of CXCR4 expression as well as migration, chemotaxis and
invasion of the cells.
In this study, the increase in CXCR4 expression in HGF-
stimulated cells may be arising from enhanced transcription, but
more importantly, from the prolonged time of membrane receptor
exposure. Previous studies and our results on anti-CXCR4 Ab
internalization suggested that HGF treatment led to a reduction in
CXCR4 endocytosis. Consistent with published data, we also
noted that HGF-activated CXCR4 expression was attenuated in
the presence of PKCf inhibitor. The level of CXCR4 receptor
expression may affect the strength of receptor signaling and
determine the pattern of receptor-mediated effects. Protein
phosphorylation is the most prevalent posttranslational modifica-
tion and plays a major role in regulating protein function [49].
More importantly, as one of the earliest events in regulating G
protein-coupled receptor (GPCR) signaling, phosphorylation
initiates a process known as desensitization. Recent studies
demonstrated that site-specific phosphorylation of CXCR4 is
dynamically regulated by multiple kinases, which results in both
positive and negative modulation of CXCR4 signaling [10]. The
present study showed that CXCR4 phosphorylation was induced
by HGF treatment in MDA-MB-436 or MCF-7 cells, and was
attenuated by inhibition with PKCf. Therefore, we suggested that
CXCR4 expression and CXCR4 phosphorylation correlate with
PKCf in the HGF-mediated effects.
Attempts to elucidate the molecular mechanisms underlying
HGF-induced CXCR4 expression led to our interest in the role of
Rac1, a member of the Ras superfamily of small guanosine
triphosphatases (GTPases) that act as molecular switches to control
cytoskeletal rearrangements and cell growth [50]. Indeed, the Rac
family proteins, which are effectors of HGF signaling, are critical
regulators of chemokine-induced integrin activation and motility
[51]. Chianale and coworkers [23] have shown that in the
presence of diacylglycerol kinase a, HGF promotes dissociation
(from Rac/RhoGDI complex) and activation of Rac, which in
turn promotes cytoplasm-to-membrane translocation and phos-
phorylation of PKCf. Meanwhile, activated Rac-1 interacts with
CXCR4 in lipid rafts on the cell surface resulting in enhanced
sensitivity and responsiveness of hematopoietic cells to an SDF-1
gradient [52]. Other findings [53] indicated that binding of Rac1
to Part6 may lead to PKCf phosphorylation. Consistent with these
studies, our results confirmed that: (1) HGF can promote Rac
activation, which further promotes the cytoplasm-to-membrane
translocation and phosphorylation of PKCf; (2) HGF stimulation
contribute to longer duration for CXCR4 on cell membrane and
reduce the CXCR4 endocytosis caused by CXCR4 antibodies. (3)
NSC23766, a specific Rac1 inhibitor, can inhibit the activation of
Rac1 and impair the HGF-induced PKCf phosphorylation; and
(4) Blocking PKCf phosphorylation subsequently interfered with
the membrane expression and phosphorylation of CXCR4.
Therefore we hypothesized that HGF induces Rac recruitment
at ruffling sites, which may prolong the membrane expression of
CXCR4/Rac-1, and reduce the CXCR4 endocytosis caused by
chemoattractants and/or CXCR4 antibodies, thereby stimulating
the chemotaxis and migration of tumor cells. Subsequently, our
findings suggested that functional Rac1 is required for HGF-
induced PKCf activation. Rac1 and PKCf constitute a signaling
pathway of HGF-induced CXCR4 expression.
Thus far, a further elucidation is needed for the molecular
mechanism that governs HGF-induced PKCf activation and
CXCR4 expression. We know that HGF triggers motility
dependently on the activation of several intracellular molecular
pathways. The roles of PI 3-kinases [54,55], Ras and 41/43 kDa
mitogen-activated protein kinase [56] in HGF-mediated cell
scattering activity have also been established. PI 3K exists in a
wide variety of cells and could be activated by most receptor
tyrosine kinases, G protein-coupled receptors and non-receptor
tyrosine kinase relative receptors. Akt is one of the downstream
signals of the PI 3K pathway and is also a serine/threonine kinase.
Recently, PI 3-kinase has been shown to mediate lymphocyte
Figure 4. Overexpressed CXCR4 in HGF-stimulated MDA-MB-436 cells is functional. (A–B). Confluent cells were grown in 0.5% FBS
medium for 24 hours and were then wounded with a tip. The cells were washed, and the medium was replaced with or without addition of HGF, PSf
peptides or AMD3100. Representative micrographs of the wounds are shown together with the results of the migration quantification. Results are
presented as the mean 6 SD of 3 independent experiments. # P,0.01 as compared to PBS. Original magnification, 2006. (C).Dose and time-
dependent response of HGF-induced MDA-MB-436 cell migration. (D).Dose-dependent response of HGF-induced MDA-MB-436 cell chemotaxis.
(E).PKC and CXCR4 regulate HGF-mediated chemotaxis. MDA-MB-436 cells were incubated for 30 minutes with 10 mM chelerythrine chloride, an
inhibitor of all PKC, or for 1 hour with 10 mM of PS-a/b, PS-e,o rP S f peptide. (F). Boyden chamber assays were performed using the SDF-1 ligand for
CXCR4 as a chemotactic attractive agent in the lower chamber. AMD3100, PSf,P S a/b,P S e and NSC23766 (upper) or PKCf-siRNA (lower) was added to
the cell culture for the blocking assay. Data are shown as the mean 6 SD of three experiments. A representative study is shown. (G). qRT-PCR analysis
of the MT1-MMP mRNA extracted from MDA-MB-436 cells cultured for 24 hours with the indicated agents. Results are presented as the mean 6 SD of
three independent experiments. # P,0.01 as compared to PBS. (H). Western blot analysis of the total protein expression levels of MT1-MMP in MDA-
MB-436 cells cultured for 24 hours with the indicated agents. The experiment was repeated three with similar results. A representative study is
shown.
doi:10.1371/journal.pone.0029124.g004
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order to investigate whether PI3K/Akt were involved in the effects
of HGF-induced CXCR4 expression in MDA-MB 436 cells, we
examined the changes of CXCR4 expression after HGF-induced
PKCf activation by PI3K/Akt inhibitors. Western blot assays and
immunofluorescent staining data suggested that PI 3K/Akt are
required for PKCf activation and CXCR4 expression. Further-
more, Rac1 activation is also dependent on PI3-kinase activity.
The lack of complete inhibition may indicate that activation of a
small percentage of Akt/PKB is sufficient for chemotaxis, or that
an unidentified signaling molecule downstream of the PI 3K
shares a partially redundant function with Akt/PKB. Those results
also indicated that the mechanism of HGF-induced CXCR4
expression in the MDA-MB-436 breast cancer cell line involved a
pathway of activation of the PKCf and PI 3K/Akt, and that
signals stimulated by HGF passed on from PI 3K/Akt to Rac1 and
Figure 5. HGF results in PI3K/Akt pathway phosphorylation and activates CXCR4 phosphorylation via PKCf. (A). Detection of
phosphorylated Akt or of the respective total Akt protein expression and Rac1-GTP or total Rac1 expression by western blot analysis. MDA-MB-436
cells were added with PBS or were exposed to HGF/SF (for 10 minutes at 50 ng/ml) after preincubation with the PI3-kinase inhibitors wortmannin (at
100 nM, for 60 min) or LY 294002 (at 10 mM, for 60 min) as indicated. The experiment was repeated twice with similar results. A representative study
is shown. (B) Membrane CXCR4 expression in MDA-MB-436 cells cultured in the absence or presence of wortmannin (100 nM) or LY 294002 (50 mM,
starting 1 hour prior to HGF/SF treatment) with or without HGF/SF treatment (for 16 hour at 50 ng/ml) as indicated. The flow cytometry analysis data
are shown in arbitrary units (AU) as the mean 6 SD of three independent experiments. # P,0.01 as compared to PBS. (C) MDA-MB-436 cells were
exposed to HGF with or without PI 3-kinase inhibitor LY294002 (30 mM) or Akt inhibitor III (50 mM) for various amounts of time, which resulted in the
phosphorylation of PKCf. Western blotting of total protein were performed in triplicate. A representative study is shown. (D). Cellular distribution of
PKCf and CXCR4 before and after 30 minutes of HGF stimulation. HGF, 50 ng/ml, for 10 minutes; LY294002, 30 mM, for 60 min. The experiment was
repeated three times with similar results. A representative study is shown.
doi:10.1371/journal.pone.0029124.g005
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PLoS ONE | www.plosone.org 11 January 2012 | Volume 7 | Issue 1 | e29124then to PKCf. These were further supported by the fact that
multiple chemical inhibitors and PSf can block signal transmis-
sion.
MT1-MMP, also known as MMP-14, has a single transmem-
brane domain and is an integral membrane protein with an
extracellular catalytic domain suggested to be a key enzyme in
tumor metastasis and angiogenesis. Numerous studies implied that
MT1-MMP in breast tumors are correlated with the outcome of
patients with breast cancer [39]. Reduction of MT1-MMP from
the breast cancer cells resulted in significant reduction of in vitro
invasiveness and loss of response to an invasion stimulus. An
association between MT1-MMP and the PKCf activation has
been reported. PKCf may be responsible for the increased binding
of Sp1 to MT1-MMP promoter site in shear-stressed endothelial
cell (EC) and thus the induction of MT1-MMP protein [40].
MT1-MMP in coordination with CXCR4 promotes invasion and
dissemination of the tumor [41]. HGF has also been shown to
actively promote production of MT1-MMP in MDA-MB 231
cells, which further activated MMP2 and enhanced the invasive-
ness of breast cancer cells [39]. Thus, we hypothesized that PKCf
may be involved in the signaling pathway that mediates MT1-
MMP expression in cells exposed to HGF. Our data were
consistent with the requirement of PKCf phosphorylation and
activation for Rac1 increased MT1-MMP expression by MDA-
MB 436 cells. Inhibition of PKCf, Rac-1 and phosphatidylinositol
3-kinase by their respective inhibitors PSf, NSC23766 and
LY290042 attenuated MT1-MMP expression in MDA-MB 436
cells. Therefore, the proper function of MT1-MMP may depend
on both cellular expression and specific membrane localization.
This study demonstrated that PKCf is critical to regulation of
MT1-MMP expression. Activation of PKCf is also required in
both EGFR- and chemokine receptor-mediated chemotaxis,
suggesting the use of PKCf as a promising target for more potent
anti-metastasis therapeutic strategies. Because PKCf-deficient
mice are grossly normal, the pharmacologic inhibition of this
enzyme should not be lethal to the hosts [57]. The identification of
PKCf as a convergence point of EGFR- and chemokine receptor-
mediated chemotaxis provided us with a potential novel target for
anticancer drugs. We postulated that blocking PKCf may
completely impair the chemotactic activities of some cancer cells
and result in reduced in tumor invasion and spreading.
Taken together, the results of our study provided new insights to
molecular regulation of CXCR4 and to certain distinct regulatory
molecules that can be targeted to modulate the CXCR4 signaling
in breast cancer.
Materials and Methods
Patients and tissue samples
Samples of primary ductal carcinoma of the breast were
obtained from 197 female patients (median age 43.7 years, range
23–75) at the Sun Yat-Sen Memorial Hospital, Sun Yat-Sen
University, from January 2002 to October 2007. Both the
pathological diagnosis and estrogen receptor (ER)/Her2 status
were verified independently by two pathologists. Patients with
invasive carcinomas other than ductal carcinomas in-situ (DCIS)
underwent 6 cycles of postoperative adjuvant chemotherapy with
the FAC regimen (500 mg/m
2 5-fluorouracil, 50 mg/m
2 doxoru-
bicin and 500 mg/m
2 cyclophosphamide). Patients with ER+
tumors subsequently underwent endocrine therapy according to
the NCCN guidelines. Distal metastasis was not found in these
patients upon diagnosis but was identified in 45 cases during the
postoperative follow-up. Additionally, benign breast tissue samples
were collected from 20 cases of benign diseases of the breast with
or without atypical epithelial hyperplasia. All samples were
collected with patient informed consent according to the Internal
Review and Ethics Boards of the Sun Yat-Sen Memorial Hospital
of Sun Yat-Sen University.
Cell cultures
The human breast cancer cell lines MDA-MB-436 and MCF-7
were obtained from the American Type Culture Collection. They
were cultured in L-15 or RPMI 1640 (Gibco, Birmingham, USA)
with 10% fetal bovine serum (FBS) (Gibco, Birmingham, USA).
Chemotaxis chambers and membranes were purchased from
Costar.
Wound healing assay
The wound healing assay was mainly performed as described
previously [53] with a slight modification. MDA-MB-436 breast
cancer cells were grown were grown to confluence in 6-well tissue
culture plates. The cells were pretreated with mitomycin (10 mg/
ml) for 2 h to block proliferation and then cell-free area introduced
by scratching with a pipette tip. Cancer cells were allowed for a
24-hour recovery period to close the wound and were photo-
graphed using phase-contrast microscopy.
Chemotaxis assays
The chemotaxis assays were performed as described by the
manufacturer (Costar, Corning, NY, USA). Briefly, MDA-MB-
436 cells (5610
5 cells/ml) were pretreated with mitomycin
(10 mg/ml) for 2 h to block proliferation and then suspended in
medium (L-15, 0.1% bovine serum albumin, and 25 mM HEPES)
were added to the upper chamber. The two chambers were
separated by a 10-mm filter pretreated with 0.001% fibronectin in
L-15 at 4uC overnight. The chambers were incubated in 5% CO2
at 37uC for 12 hours. The filter was then washed, fixed, and
stained. The number of migrating cells was counted in three high-
power fields (2006). In the inhibitor assay, MDA-MB-436 cells
were pretreated with inhibitors at the indicated concentration for
60 minutes before HGF (Sigma, St. Louis, USA) were added at
37uC and then loaded into the upper chamber.
Figure 6. HGF enhances CXCR4 expression via PKCf and promotes the invasion and metastasis of breast cancers in BALB/c-nu mice.
(A) Micrographs of H&E-stained xenografts demonstrating the presence or absence of margin invasion by the MDA-MB-436 tumors untransduced
(Un) or transduced with GFP-shRNA or PKCf-shRNA (original magnification, 2006). (B) Representative micrographs of lung (upper) or liver (lower)
tissue sections with H&E staining and PCNA immunohistochemical staining (original magnification, 2006). Each group from two independent
experiments. (C) Mean 6 SD wet lung weight in tumor-bearing mice. The number of mice in each group is indicated. * P,0.05 as compared to PBS-
treated mice. (D) Expression of human HPRT mRNA relative to mouse 18S rRNA as determined by qRT-PCR in the lungs and livers of tumor-bearing
mice. Data were normalized to PBS-treated mice. # P,0.01 as compared to PBS-treated mice. (E–F) Immunoblot of total PKCf and p-PKCf or total
CXCR4 and p-CXCR4 protein, respectively, in breast tumor xenografts in female nude mice that were inoculated in the mammary fat pads with MDA-
MB-436 cells treated as indicated. The experiment was repeated twice with similar results. A representative study is shown. (G) Representative
microphotos of immunohistochemical results for p-PKCf (middle) or p-CXCR4 (lower) expression in MDA-MB-436 tumors (original magnification,
4006).
doi:10.1371/journal.pone.0029124.g006
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Invasion of breast cancer cells was examined using 24-well
Boyden chambers (Costar, Corning, NY, USA) with 8-mM inserts
coated with fibronectin (Roche, Mannheim, Germany) and
matrigel (BD Biosciences, USA). The lower chamber was filled
with L-15/BSA medium containing 10 ng/ml SDF. MDA-MB-
436 cells (5610
4 cells/well) were pretreated with mitomycin
(10 mg/ml) for 2 h to block proliferation and then were plated on
the inserts with, or without HGF/SF and cultured at 37uC in the
upper chambers. After 8 hours, invading cells that crossed the
inserts were stained with viola crystalline (0.005%, Sigma, St.
Louis, USA) and were counted as cells per field of view using
phase-contrast microscopy.
Flow cytometry of membrane and intracellular CXCR4
expression
Membrane CXCR4 expression was determined by flow
cytometry (BD, CA, USA) as described previously [11] using
anti-human CXCR4 monclonal antibody (clone 12G5) (Santa
Cruz, CA, USA), followed by secondary FITC-conjugated donkey
anti-mouse IgG. Isotype matched IgG2a was used as control,
showing background labeling with no differences between the
treatments. Ratios of mean values of Ab labeled cells to secondary
IgG only control samples were calculated using Cell Quest
software (BD, CA, USA), and the results were expressed in
arbitrary units (AU). Flow cytometry analysis with additional anti
CXCR4 mAbs, clones 6H8 and 1D9, demonstrated similar to
12G5 increase following HGF treatment. For the analysis of
intracellular CXCR4 levels, MDA-MB-436 cells were immunola-
beled with anti-human CXCR4 mAb after blocking the
membrane receptors by a 1-hour incubation with 10 mg/ml
non-conjugated 12G5 mAb. Membrane CXCR4 internalization
was assayed as previously described: MDA-MB-436 cells were pre-
incubated for 30 minutes at 4uC with 10 mg/ml of anti human
CXCR4-PE Ab, transferred to 37uC for the indicated times, and
then washed for 2 minutes on ice at acidic (pH2.2) buffer to
remove the surface-bound Ab. The relative proportion (%) of
internalized receptor (labeling after acid wash) with respect to total
fluorescence intensity was determined by flow cytometry.
CXCR4 and protein kinase C f translocation assay
Cells were cultured for 48 hours before the experiment. They
were then starved in binding medium for 3 hours, followed by
stimulation with 50 ng/ml HGF at 37uC for 10 minutes before
fixation with 4% formaldehyde. As the inhibitor control, cells were
treated with 50 mM NSC23766 (Santa Cruz, CA, USA) at 37uC
for 1 hour before HGF stimulation. Cells were then permeabilized
with 0.2% Triton X-100 in buffer (10 mM HEPES, 20 mM
KH2PO4, 5 mM EGTA, 2 mM MgCl2, PBS, pH 6.8), stained
with polyclonal antibodies against various PKC isotypes and
probed with FITC-labeled goat anti-rabbit antibody. CXCR4 was
labeled with 10 mg/ml anti-human CXCR4 mAb. Cells were
visualized using a Zeiss LSM 710 inverted fluorescent confocal
microscope (Carl Zeiss, Inc, Germany).
qRT-PCR
qRT-PCR was performed using an ABI Prism 7000 System
(Applied Biosystems, Waltham, MA, USA). SYBR Green was used
to detect the PCR products. All reactions were performed in
triplicate in a 20-ml reaction volume. Primers for human CXCR4,
MT1-MMP, GAPDH, HPRT and mouse 18S rRNA were
obtained from Takara (Table S3). PCR amplification consisted
of an initial denaturation step at 95uC for 5 min, followed by 40
cycles of PCR at 95uC for 20 s, 60uC for 30 s. Standard curves
were generated, and the relative amount of target gene mRNA
was normalized to GAPDH mRNA. Specificity was verified by
melt curve analysis and agarose gel electrophoresis. To quantify
cancer metastasis in mouse lungs and livers, qRT-PCR for human
hypoxanthine-guanine phosphoribosyltransferase (hHPRT) was
performed on TRIzol-isolated total RNA using the primers
described for hHPRT and mouse 18S rRNA. After reverse
transcription for 45 min at 42uC and Taq activation for 3 min at
95uC, 40 cycles of PCR at 95uC for 12 s and 60uC for 15 s were
performed. The relative amount of hHPRT mRNA was
normalized to mouse 18S rRNA.
Transfections
Transient transfections and siRNA-mediated protein silencing
in MDA-MB-436 cells were performed using Lipofectamine 2000
reagent (Invitrogen, Carlsbad, CA, USA) according to the
manufacturer’s instructions. siRNAs were chemically synthesized
as double-stranded RNA (GenePharma Co., Ltd., Shanghai,
China). siRNAs against canine PKCf [23]or Rac1 [58] have been
described as follows: PKCf-siRNA 1 sense: 59-GGCUGUUC-
CUGGUCAUAGA-39; antisense: 59-UCUAUGACCAGGAA-
CAGCC-39. PKCf-siRNA 2 sense: 59-GGUGCACACUUUC-
CACAGA-39; antisense: 59-UCUGUGGAAAGUGUGCACC-39.
Rac1-siRNA sense: 59-GAGGCCUCAAGACAGUGUUU-
GACGA-39; Rac1-siRNA antisense: 59-UCGUCAAACACUGU-
CUUGAGGCCUC-39. GFP-siRNA (GenePharma Co., Ltd.,
Shanghai, China) was used as negative control.
Western blotting assay
Western blotting was carried out as described previously [59].
Briefly, protein extracts were resolved by 10% SDS-PAGE,
transferred to PVDF membranes, and probed with antibodies
against human CXCR4 (Abcam, Cambridge, MA, USA),
phosporylated CXCR4 (p-CXCR4) (Abcam, Cambridge, MA,
USA), PKCf (Bioworld, Louis Park, MN, USA), phosporylated
PKCf (p-PKCf) (Bioworld, Louis Park, MN, USA), Akt/PKB
(Santa Cruz, CA, USA), phosporylated Akt/PKB (Santa Cruz,
CA, USA), Rac1 (Santa Cruz, CA, USA), Met (Bioworld, Louis
Park, MN, USA), phosporylated Met (p-Met) (Bioworld, Louis
Park, MN, USA), MT1-MMP(Abcam, Cambridge, MA, USA)
and visualized by an enhanced chemiluminescence assay (Pierce).
Rac activation assay
Rac1 activity was measured using the rac1 activation assay kit
(Upstate Biotechnology, NY, USA) with slight modification.
Briefly, whole-protein extracts were immunoprecipitated with
protein binding domain of p21 activation kinase-1 (PAK1-PBD).
PAK1-PBD only binds to activated forms of rac1 and cdc42.
Immunoprecipitated proteins were separated in SDS-PAGE (10%)
and blotted with anti-rac1 (Santa Cruz BiotechnologyInc., CA,
USA).
Immunohistochemistry
For immunohistochemistry analysis, anti-p-PKCf monoclonal
antibody or anti-p-CXCR4 polyclonal antibody was used as the
primary antibody for overnight incubation at 4uC. The sections
were subsequently treated with secondary antibody, followed by
further incubation with the streptavidin-horseradish peroxidase
complex. Diaminobenzidine was used as a chromogen, and
sections were lightly counterstained with hematoxylin. The
percentage of p-PKCf- and p-CXCR4-positive tumor cells was
calculated by counting 1,000 tumor cells.
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MCF-7 cells and MDA-MB 436 cells (3610
5/100 ml) were
cultured in serum-free medium with HGF (50 ng/ml) and/or PS-f
peptides (10 mM), AMD3100 (1 mM), NSC23766 (25 mM). After 3
days, [
3H]-thymidine (1 mCi/well; Amersham Biosciences) was
added, and the cells were cultured for an additional 16 hours.
Then the cells were harvested onto fiberglass filters, and detected
for their radioactivity in a Matrix-96 direct b counter (Packard
Instrument Co.). Cell viability was determined by the MTS
colorimetric assay using tetrazolium reagent. MCF-7 cells and
MDA-MB 436 cells (5610
3/500 ml) were cultured in serum-free
RPMI with indicated agents. After 4 days, 20 ml of MTS solution
were added to each well and incubated at 37uC for 2 hours.
Absorbance at 490 nm, which is directly proportional to the
number of living cells, was measured on a 96-well plate reader.
Data are expressed as a percentage of the untreated cells cultivated
under the same conditions.
Tumor xenografts
Four groups of eight female BALB/c-nu mice each were
introduced to the experiment. MDA-MB-436 (2610
6) breast
cancer cells that were untransfected or transfected with GFP-
shRNA or PKCf-shRNA were inoculated into the mammary fat
pads of female BALB/c-nu mice. When the xenografts were
palpable (approximately 5 mm in diameter), intratumoral injec-
tion of PBS or 30 mg/kg HGF was performed biweekly for four
consecutive weeks. Tumor growth was evaluated by monitoring
the tumor volume (TV=length6width
260.5) every three days for
eight weeks. The animals were sacrificed when the xenografts
reached 1.5 cm in diameter, and the mouse tumor xenografts,
lungs and livers were harvested for further evaluation. Cryosec-
tions (4 mm) of the harvested organs were stained with hematox-
ylin and eosin (HE) for histological assessment, and total RNA was
extracted for qRT-PCR analysis of human HPRT mRNA
expression.
Statistics
All in vitro experiments were performed either in triplicate or in
quintuplicate. Standard software 13.0 (SPSS, Chicago, IL) was
used for statistical analyses. Measurement data were presented as
mean 6 standard deviation (SD). Statistical analysis was
performed by one-way analysis of variance (ANOVA). The
differences between the means were tested by an independent
sample t-test or Bonferroni’s multiple comparison t-test. The x
2
test was used to compare percentages. The significance level used
was P,0.05.
Supporting Information
Figure S1 HGF upregulates CXCR4 expression and
membrane presentation in human breast cancer cells.
(A). Western blotting analysis revealed that the protein levels of
CXCR4 and p-CXCR4 treated with HGF were higher than those
treated with SDF in MDA-MB- 436 (left panel) and MCF-7 cells
(right panel). Data are shown in arbitrary units (AU) normalized to
PBS as the mean 6 SD of three independent experiments. #
P,0.01 as compared to PBS. (B). Western blotting analysis
revealed that the protein levels of Met and p-Met treated with
HGF were higher than those treated with SDF in MDA-MB- 436
(left panel) and MCF-7 cells (right panel). Data are shown in
arbitrary units (AU) normalized to PBS as the mean 6 SD of three
independent experiments. # P,0.01 as compared to PBS.
(C).Time course of relative CXCR4 content in two breast cancer
cells following 50 ng/ml HGF stimulation. Data are shown in
arbitrary units (AU) normalized to PBS as the mean 6 SD of three
independent experiments. # P,0.01 as compared to PBS.
(TIF)
Figure S2 HGF-induced increase in CXCR4 expression
depends on PKCf activity. (A). Time course of relative p-
PKCf levels as determined by immunoblot in MDA-MB-436 (left
panel) and MCF-7 cells(right panel) following stimulation with
50 ng/ml HGF. Data are shown in arbitrary units (AU)
normalized to PBS as the mean 6 SD of three independent
experiments. # P,0.01, *P,0.05 as compared to PBS.
(B).100 mM PKCf-siRNA1 (si1) or PKCf-siRNA2 (si2) transient
transfections and siRNA-mediated PKCf protein silencing in
MDA-MB-436 cells. Data are shown in arbitrary units (AU)
normalized to PBS as the mean 6 SD of three independent
experiments. # P,0.01 as compared to PBS. (C). Western blot
analysis of PKCf(left panel) and CXCR4(right panel)expression
levels in MDA-MB-436 cells cultured for 24 hours with 50 ng/ml
HGF or/and 100 mM PKCf-siRNA1 (si1) or PKCf-siRNA2 (si2).
Data are shown in arbitrary units (AU) normalized to PBS as the
mean 6 SD of three independent experiments. # P,0.01 as
compared to PBS. (D) and (E). Western blot analysis of total
CXCR4 expression and p-CXCR4 levels in MDA-MB-436 cells
cultured for 24 hours with 50 ng/ml HGF, 2 mM cholesterol
sulfate (Choles sul), or PBS. As indicated, 10 mM PS of PKCf
(PSf), PKCe (PSe), or PKCa/b (PSa/b)o r2 5mM NSC23766 was
used. Data are shown in arbitrary units (AU) normalized to PBS as
the mean 6 SD of three independent experiments. #
P,0.01*P,0.05 as compared to PBS. (F). Western blot analysis
of Rac1-GTP and total-Rac1 in MDA-MB-436 and MCF-7 cells
treated with 50 ng/ml HGF with or without 25 mM NSC23766.
The experiment was repeated three times with similar results. A
representative study is shown. # P,0.01 as compared to PBS. (G).
Dose-dependent inhibition of HGF-induced p-PKCf was achieved
using NSC23766 in HGF-treated MDA-MB-436 cells; the cells
were assayed by Western blot. Data are shown in arbitrary units
(AU) normalized to PBS as the mean 6 SD of three independent
experiments. # P,0.01 as compared to PBS. (H). Western blot
analysis of Rac1, PKCf and CXCR4 expression in MDA-MB-436
cells treated with 100 mM Rac1-siRNA for 48 hours. Data are
shown in arbitrary units (AU) normalized to PBS as the mean 6
SD of three independent experiments. # indicates P,0.01 as
compared to PBS.
(TIF)
Figure S3 Overexpressed CXCR4 in HGF-stimulated
MDA-MB-436 cells is functional. (A–B). MDA-MB-436 cells
were treated with indicated agents determined by Boyden
chamber assays. Cells were counted in triplicate wells and in
three identical experiments. Data are shown in invasion index
normalized to PBS as the mean 6 SD of three independent
experiments. # P,0.01 as compared to PBS. (C). Effect of HGF
on breast cancer cell proliferation. MDA-MB 436 and MCF-7 cell
lines were cultured for 3 days in serum-free medium with HGF
(50 ng/ml) and/or other indicated agents, [
3H]-thymidine (1 mCi/
well; Amersham Biosciences) was added for an additional
16 hours. Cells were harvested onto fiberglass filters, and
radioactivity was detected in a Matrix-96 direct b counter
(Packard Instrument Co.) Results shown are representative of
three independent experiments. (D). For the MDA-MB 436 and
MCF-7 cells were cultured in the presence of HGF and/or other
indicated agents for 4 days. Cell viability was determined by MTS
assay and reported as a percent of untreated cells. Results shown
are representative of three independent experiments. (E). Western
blot analysis of the total protein expression levels of MT1-MMP in
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agents. Data are shown in arbitrary units (AU) normalized to PBS
as the mean 6 SD of three independent experiments. # P,0.01
as compared to PBS.
(TIF)
Figure S4 HGF results in PI3K/Akt pathway phosphor-
ylation and activates PKCf phosphorylation. (A). Detec-
tion of phosphorylated Akt or of the respective total Akt protein
expression or Rac1-GTP and total-Rac1 by western blot analysis.
MDA-MB-436 cells were left with PBS or were exposed to HGF/
SF (for 10 minutes at 50 ng/ml) after preincubation with the PI3-
kinase inhibitors wortmannin (at 100 nM, for 60 min) or LY
294002 (at 10 mM, for 60 min) as indicated. Data are shown in
arbitrary units (AU) normalized to PBS as the mean 6 SD of three
independent experiments. # P,0.01 as compared to PBS. (B).
MDA-MB-436 cells were exposed to HGF with or without PI 3-
kinase inhibitor LY294002 (30 mM) or Akt inhibitor III (50 mM)
for various amounts of time, which resulted in the phosphorylation
of PKCf. Data are shown in arbitrary units (AU) normalized to
PBS as the mean 6 SD of three independent experiments.
* indicates P,0.05, # indicates P,0.01 as compared to PBS.
(TIF)
Figure S5 Treatment with HGF slightly enhanced the
tumor growth of breast cancer xenografts in BALB/c-nu
mice. Tumor volume in the mammary fat pads was monitored in
BALB/c-nu mice xenografted with MDA-MB-436 (2610
6 cells)
breast cancer cells that were uninfected or infected with GFP-
shRNA or PKCf-shRNA. Biweekly intratumoral injection with
PBS or 30 mg/kg HGF was performed for 4 consecutive weeks
once the xenografts were palpable (around 5 mm in diameter).
The number of mice with detectable tumors is indicated.
(TIF)
Figure S6 HGF enhances CXCR4 expression via PKCf
and promotes the invasion and metastasis of breast
cancers in BALB/c-nu mice. (A–B) Immunoblot of total
PKCf and p-PKCf (A) or total CXCR4 and p-CXCR4 (B)
protein, respectively, in breast tumor xenografts in female nude
mice that were inoculated in the mammary fat pads with MDA-
MB-436 cells treated as indicated. Data are shown in arbitrary
units (AU) normalized to PBS as the mean 6 SD of three
independent experiments. # indicates P,0.01 as compared to
PBS.
(TIF)
Figure S7 Expression of phosphorylated PKCf or phos-
phorylated CXCR4 was reduced in breast cancer cells
transduced with PKCf-shRNA. (A–B)Breast cancer cells
expressing phosphorylated-PKCf (A) or phosphorylated-CXCR4
(B) were count per field of view and were determined by
immunohistochemical staining of tumor lesions from mice bearing
breast cancer xenografts transduced with PKCf-shRNA. #
P,0.01 as compared to PBS-treated mice.
(TIF)
Figure S8 HGF enhances CXCR4 expression via PKCf
and promotes the invasion and metastasis of breast
cancers in BALB/c-nu mice. Representative micrographs of
the lungs and livers of each group from two independent
experiments.
(TIF)
Table S1 CXCR4 and phospho-c-Met
+ counts as related
to clinicopathological status in 197 cases of breast
cancer patients. Note: *, grading in 197 cases of invasive
ductal carcinoma; #, distant metastasis was identified during
postoperative follow-up.
(DOC)
Table S2 Incidence of tumors from MDA-MB-436 cells
inoculated in BALB/c-nu mice. Notes: *, P,0.05 vs. PBS.
(DOC)
Table S3 Primers for qRT-PCR.
(DOC)
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